Enterobiome specializes in Akkermansia muciniphila and Faecalibacterium prausnitzii which are next-generation probiotics. Those bacterial species among human intestinal microorganisms have been shown to have a causal relationship with incurable diseases through research. Around the world, A. muciniphila comes to next-generation probiotics and commercial products are rising worldwide. Available business opportunities such as licensing out and co-development.
| Sales markets | Asia; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Affiliated categories: | Other Microorganisms & Probiotics |Other Prebiotics |Biotic products More |